Validity of the relationship between mobility group box-1 protein and poor post–cardiac arrest neurological outcome during renal replacement therapy
Main Authors: | Patrick M. Honore, David De Bels, Luc Kugener, Sebastien Redant, Rachid Attou, Andrea Gallerani, Herbert D. Spapen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Critical Care |
Online Access: | http://link.springer.com/article/10.1186/s13054-018-2302-8 |
Similar Items
-
Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
by: Patrick M. Honore, et al.
Published: (2019-01-01) -
Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose
by: Patrick M. Honore, et al.
Published: (2018-08-01) -
Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
by: Patrick M. Honore, et al.
Published: (2020-03-01) -
No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
by: Patrick M. Honore, et al.
Published: (2020-02-01) -
Hyperchloremia-associated acute chronic kidney injury: beware of confounders!
by: Patrick M. Honore, et al.
Published: (2019-01-01)